Skip to main content
Clinical Trials/CTRI/2019/03/018217
CTRI/2019/03/018217Active, not recruitingPhase 4

Efficacy of potassium rich diet (coconut water) as add on therapy in inducing remission in patients with mild to moderate ulcerative colitis: a randomized control trial

Dept of Gastroenterology0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients who are confirmed cases of mild ulcerative colitis (of any disease extent) as assessed by Mayo score (4-6), within 1 week of relapse
  • 2.Age: 18 â?? 70 years of either gender
  • 3.Patients on stable dose of mesalamine for past 4 weeks
  • 4.Patients on stable dose of azathiopurine/ 6-mercaptopurine for past 6 months
  • 5.Ready to participate

Exclusion Criteria

  • 1.H/O of oral steroids in the past 4 weeks
  • 2.H/O or oral antibiotics within past 2 weeks
  • 3.H/O topical therapy within 1 week
  • 4.Patients with severe disease activity
  • 5.Patients with fulminant colitis requiring hospitalization
  • 6.Patients who have had surgery
  • 7.Patients with Crohnâ??s colitis
  • 8.Patients with concomitant GI infection
  • 9.Patients on drugs that can affect potassium homeostasis (ACE-inhibitors, angiotensin receptor blockers, aldosterone antagonists)
  • 10.Patients with comorbidities like acute myocardial infarction, chronic kidney disease or chronic liver disease or any other condition which precludes high potassium diet
  • 11.Patients with significant hepatic, renal, endocrine, respiratory, neurologic, or cardiovascular diseases will also be excluded
  • 12.Pregnant, lactating females

Investigators

Sponsor
Dept of Gastroenterology

Similar Trials